AdaptHealth AHCO Respiratory Health — Adjusted EBITDA
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AdaptHealth in its filing.
Tagged under the XBRL concept ahco:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization.
The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about AdaptHealth's respiratory health — adjusted ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AdaptHealth's respiratory health — adjusted EBITDA?
- AdaptHealth (AHCO) reported respiratory health — adjusted EBITDA of $50.04M in Q1 2026.
- How has AdaptHealth's respiratory health — adjusted EBITDA changed year-over-year?
- AdaptHealth's respiratory health — adjusted EBITDA increased by 10.0% year-over-year, from $45.48M to $50.04M.
- What is the long-term trend for AdaptHealth's respiratory health — adjusted EBITDA?
- Over 3 years (2022 to 2025), AdaptHealth's respiratory health — adjusted EBITDA has grown at a 9.1% compound annual growth rate (CAGR), from $161.41M to $209.75M.
- What does respiratory health — adjusted EBITDA mean?
- This is a non-GAAP measure of the respiratory health segment's operational profitability, excluding interest, taxes, depreciation, amortization, and other non-cash or non-recurring charges. It allows investors to assess the core cash-generating capability of the segment independent of capital structure.